Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)

Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life. The emetogenicity of the chemotherapeutic agents, repeated chemotherapy cycles, and patient risk factors significantly influence CINV. The use of a combination of a 5-hydroxytryptamine-...

Descripción completa

Detalles Bibliográficos
Autor principal: Navari, Rudolph M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277122/
https://www.ncbi.nlm.nih.gov/pubmed/25552904
http://dx.doi.org/10.2147/DDDT.S76158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277122/
https://www.ncbi.nlm.nih.gov/pubmed/25552904
http://dx.doi.org/10.2147/DDDT.S76158

Ejemplares similares